Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Health Technology » Pharmaceuticals Other
|SAVA||Cassava Sciences, Inc.||0.00%||45.88||0.0%||$167.43m|
|VRX||Valeant Pharmaceuticals International, Inc.||-0.04%||27.07||14.1%||$159.28m|
|BHC||Bausch Health Cos., Inc.||-0.04%||27.07||0.0%||$112.90m|
|HZNP||Horizon Therapeutics Plc||0.00%||91.10||5.4%||$106.55m|
|JAZZ||Jazz Pharmaceuticals Plc||0.00%||144.30||2.1%||$88.31m|
|UTHR||United Therapeutics Corp.||0.00%||213.96||13.9%||$83.03m|
|PRGO||Perrigo Co. Plc||0.03%||39.74||6.9%||$50.64m|
|BRBR||BellRing Brands, Inc.||0.04%||25.93||0.0%||$28.46m|
|PCRX||Pacira Biosciences, Inc.||0.00%||64.08||9.8%||$26.06m|
|CORT||Corcept Therapeutics, Inc.||0.00%||18.45||5.5%||$21.72m|
|SAGE||SAGE Therapeutics, Inc.||0.00%||42.93||7.6%||$19.98m|
|IRWD||Ironwood Pharmaceuticals, Inc.||0.00%||11.72||9.5%||$19.47m|
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development and commercialization of medications to treat severe metabolic, oncologic and psychiatric disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.